MSB11456 in Participants With Moderately to Severely Active Rheumatoid Arthritis
Clinical trial NCT04512001 · COMPLETED
Trial details
- NCT number
- NCT04512001
- Sponsor
- Fresenius Kabi SwissBioSim GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-03
- Primary completion
- 2021-08-31
- Enrollment
- 604
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.